Evidence map›Paper›PMID 30209176›Full record

ArticleJournal of virology2018

HOIL1 Is Essential for the Induction of Type I and III Interferons by MDA5 and Regulates Persistent Murine Norovirus Infection.

Donna A MacDuff, Megan T Baldridge, Arwa M Qaqish, Timothy J Nice, Azad D Darbandi, Victoria L Hartley, Stefan T Peterson, Jonathan J Miner, Kazuhiro Iwai, Herbert W Virgin

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 46 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Review
  6. HOIL1 mediates MDA5 activation through ubiquitination of LGP2.bioRxiv : the preprint server for biology · 2024
    Article
  7. LUBAC is required for RIG-I sensing of RNA viruses.Cell death and differentiation · 2024
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. The RING finger protein family in health and disease.Signal transduction and targeted therapy · 2022
    Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Donna A MacDuff *Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA dmacduff@uic.edu virgin@wustl.edu.ORCID 0000-0002-6183-6827
Megan T Baldridge *Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA.
Arwa M QaqishDepartment of Microbiology and Immunology, University of Illinois at Chicago, Chicago, Illinois, USA.
Timothy J NiceDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA.
Azad D DarbandiDepartment of Microbiology and Immunology, University of Illinois at Chicago, Chicago, Illinois, USA.
Victoria L HartleyDepartment of Microbiology and Immunology, University of Illinois at Chicago, Chicago, Illinois, USA.
Stefan T PetersonDepartment of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.
Jonathan J MinerDepartment of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.
Kazuhiro IwaiDepartment of Molecular and Cellular Physiology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Herbert W VirginDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA dmacduff@uic.edu virgin@wustl.edu.
Washington University in St. Louis · USUniversity of Illinois Chicago · USKyoto University · JP

Funding

Genetic and Pathway Analysis CoreU19AI109725 · NIAID · WASHINGTON UNIVERSITY · PI ALLEN, PAUL M · 2014 to 2018
$32.7M
TRAINING IN THE IMMUNOBIOLOGY AND MOLECULAR CELL BIOLOGY OF CANCERT32CA009547 · NCI · WASHINGTON UNIVERSITY · PI ROBERT DAVID SCHREIBER · 1986 to 2026
$12.1M
Regulation of Interferon-Lambda Signaling by Commensal Bacteria and NorovirusK22AI127846 · NIAID · WASHINGTON UNIVERSITY · PI BALDRIDGE, MEGAN T · 2017 to 2018
$270k
NCI NIH HHS T32 CA009547NIAID NIH HHS K22 AI127846NIAID NIH HHS U19 AI109725
6 · The paper itself

Abstract

The linear ubiquitin chain assembly complex (LUBAC), composed of heme-oxidized IRP2 ubiquitin ligase 1 (HOIL1), HOIL1-interacting protein (HOIP), and SHANK-associated RH domain-interacting protein (SHARPIN), is a crucial regulator of multiple immune signaling pathways. In humans, HOIL1 or HOIP deficiency is associated with an immune disorder involving autoinflammation, immunodeficiency, and inflammatory bowel disease (IBD)-like symptoms. During viral infection, LUBAC is reported to inhibit the induction of interferon (IFN) by the cytosolic RNA sensor retinoic acid-inducible gene I (RIG-I). Surprisingly, we found that HOIL1 is essential for the induction of both type I and type III IFNs, as well as the phosphorylation of IFN regulatory factor 3 (IRF3), during murine norovirus (MNoV) infection in cultured dendritic cells. The RIG-I-like receptor, melanoma differentiation-associated protein 5 (MDA5), is also required for IFN induction and IRF3 phosphorylation during MNoV infection. Furthermore, HOIL1 and MDA5 were required for IFN induction after Theiler's murine encephalomyelitis virus infection and poly(I·C) transfection, but not Sendai virus or vesicular stomatitis virus infection, indicating that HOIL1 and LUBAC are required selectively for MDA5 signaling. Moreover,

Indexed as

AnimalsCaliciviridae InfectionsCells, CulturedDendritic CellsFibroblastsGenome, ViralInterferon-Induced Helicase, IFIH1Interferon LambdaInterferon Regulatory Factor-3InterferonsInterferon Type IMiceMice, Inbred C57BLMice, KnockoutMicrobiotaNorovirusIfih1 protein, mouseInterferon-Induced Helicase, IFIH1Interferon LambdaInterferon Regulatory Factor-3InterferonsInterferon Type IRbck1 protein, mouseUbiquitin-Protein LigasesHOIL1interferonsLUBACMDA5norovirusubiquitination

Identifiers

PMID30209176
PMCPMC6232484
OpenAlexW2891275263

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.